Sphera Funds Management Ltd. Amgen Inc Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $2.26 Million - $2.75 Million	10,000 New	10,000 $2.42 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $23.8 Million - $28.3 Million	-110,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $7.04 Million - $7.83 Million	30,000 Added 37.5%	110,000 $28 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $15.8 Million - $19.4 Million	80,000 New	80,000 $18.9 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $18.5 Million - $20.9 Million	-100,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $16.6 Million - $18.7 Million	100,000 New	100,000 $18.5 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.